Diary - News
All news Novasep expands its HPAPI manufacturing capacity in Le Mans for innovative cancer therapies
Lyon, France – May 12, 2021 - Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce today a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities on its Le Mans (72 – France) site. This new step underlines customers' confidence in Novasep’s expertise in HPAPIs & ADCs and reinforces Novasep’s position as a leading CDMO for the production of innovative and targeted molecules to treat cancer.